THE RIGHT TOOL MAKES ALL THE DIFFERENCE

BiZact™ has been built for one purpose and designed in collaboration with ENTs, to optimize tonsillectomies with clinically proven benefits for you and more importantly, your patients.

A DIFFERENT APPROACH TO TONSILLECTOMY

DISCOVER THE CLINICALLY PROVEN BENEFITS OF BIZACT™([FOOTNOTE=Karni, R., Attner, P. (2018). A prospective, multi‑center, single arm, non‑comparative pilot study of BiZact on adults undergoing tonsillectomy. Data on file. Study sponsored by Medtronic. ClinicalTrials.gov Identifier: NCT02876575],[ANCHOR=],[LINK=]),([FOOTNOTE=Roje Z, Racić G, Dogas Z, Pisac VP, Timms M. Postoperative morbidity and histopathologic characteristics of tonsillar tissue following coblation tonsillectomy in children: a prospective randomized single‑blinded study. Coll Antropol. 2009;33(1):293–298.],[ANCHOR=],[LINK=]),([FOOTNOTE= Lachanas VA, Prokopakis EP, Bourolias CA, et al. LigaSure™ versus cold knife tonsillectomy. Laryngoscope. 2005;115(9):1591–1594.],[ANCHOR=],[LINK=]),†

The BiZact™ device has been clinically shown to:

  • Reduce intraoperative blood loss1,††
  • Improve procedural efficiency1,([FOOTNOTE=Lee SW, Jeon SS, Lee JD, Lee JY, Kim SC, Koh YW. A comparison of postoperative pain and complications in tonsillectomy using BiClamp forceps and electrocautery tonsillectomy. Otolaryngol Head Neck Surg. 2008;139(2):228‑234.],[ANCHOR=],[LINK=]),([FOOTNOTE=Omrani M, Barati B, Omidifar N, Okhovvat AR, Hashemi SA. Coblation™* versus traditional tonsillectomy: A double blind randomized controlled trial. J Res Med Sci. 2012;17(1):45‑50.],[ANCHOR=],[LINK=]),‡
  • Reduce the incidence of postoperative hemorrhage([FOOTNOTE=Brown, E. (2019). A prospective, multi‑center, single arm study of BiZact™ on children undergoing tonsillectomy. Data on file. Study sponsored by Medtronic. ClinicalTrials.gov Identifier: NCT03266094],[ANCHOR=],[LINK=]),([FOOTNOTE=Francis D, Fonnesbeck C, Sathe N, McPheeters M, Krishnaswami S, Chinnadurai S. Postoperative bleeding and associated utilization following tonsillectomy in children: a systematic review and meta‑analysis. Otolaryngology Head and Neck Surgery. 2017; 156(3):442‑455.],[ANCHOR=],[LINK=])

DESIGNED SPECIFICALLY FOR TONSILLECTOMY

BIZACT™ TONSILLECTOMY DEVICE OPTIMIZES THE PROCEDURE FROM START TO FINISH

Surgeons using the BiZact™ device are completing cases in about half the time1,4,5,†† compared to the Coblator™* device and electrocautery.  Because the BiZact™ device: 

  • Offers a fast and easy setup([FOOTNOTE=Based on internal test report #RE00073873 and #RE00079704, Independent surgeon and nurse feedback collected during Medtronic sponsored labs. January and February 2017.],[ANCHOR=],[LINK=]),₤
  • In‑line activation facilitates efficient sealing and transection
  • Reduces intraoperative bleeding1-3,§§,Ω

See the difference in tissue effect

LEARN FROM YOUR PEERS

3 surgeons discuss the BiZact™ tonsillectomy device

Global Webinar Recording

PROCEDURAL VIDEOS AND GUIDES

Videos

Tips to help you optimize your technique

  • † Used in 48 cases, including adults (22+) US (18+) EU the use of the BiZact™ tonsillectomy device resulted in non‑measurable bloodloss compared to published literature stating 10.83 ml for Coblator™*, 27.08 ml for electrocautery [Roje], and 125 ml [Lachanas] with cold knife.

  • †† Used in 48 cases, including adults (22+) US (18+) EU the use of the BiZact™ tonsillectomy device resulted in non‑measurable bloodloss.

  • ‡ Used in 48 cases, including adults (22+) US (18+) EU. Average procedure time for the BiZact™ tonsillectomy device was 7 min. compared to published literature stating 14.8 (pediatric) and 20.5 (adult) min. [Lee] for electrocautery and 27.3 min. [Omrani] for Coblator™*.

  • § Used in 60 cases, including patients (age range 3‑12yrs) in the U.S. There were no intra‑operative or post‑operative bleeding events, defined as bleeding events that required intervention, compared to secondary post‑operative hemorrhage rates in published literature of 6.3% for electrocautery, 4% for cold dissection, and 2.4% for coblation [Francis].

  • §§ Used in 48 cases, including adults (22+) US (18+) EU. The use of the BiZact™ tonsillectomy device resulted in non‑measurable blood loss compared to published literature stating 10.83 ml for Coblator™*, 27.08 ml for electrocautery [Roje], and 125 ml for cold knife [Lachanas].

  • ₤ 12 out of 12 surgeons and 13 out of 15 nurses surveyed agreed.

  • Ω Compared to electrocautery, Coblator™*, and cold knife.